Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide
Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide
复制标题
DOI:
10.1016/j.cyto.2013.03.025
复制
发表时间:
2013-06-01
期刊:
影响因子:
3.8
通讯作者:
Fernandez, Gabriela C.
中科院分区:
文献类型:
--
作者:
Martire-Greco, Daiana;Rodriguez-Rodrigues, Nahuel;Fernandez, Gabriela C.
Large amounts of anti-inflammatory mediators, such as interleukin (IL)-10, are produced and found early in the course of sepsis. We explore the role of IL-10 on neutrophil (PMN) activation/function using an in vitro model. Isolated human PMN were pre-incubated with lipopolysaccharide (LPS) and/or IL-10 for 18 h. Subsequently, a second LPS exposure was performed and CD11b and CD66b up-regulation, and the reactive oxygen species (ROS) generation were measured 2 h later. We found that IL-10 prevented PMN activation and the secretion of TNF-alpha and IL-8 induced by the first LPS contact. In the absence of IL-10, a second LPS exposure induced additive effects that were prevented by IL-10. Only ROS generation was highly affected by the blockade of PMN-secreted TNF-alpha or IL-8. Additionally, IL-10 prevented other possible mechanisms of LPS priming. Therefore, IL-10 modulates PMN activation preventing autocrine activating loops and priming mechanisms, rendering PMN less responsive to a second LPS exposure. (C) 2013 Elsevier Ltd. All rights reserved.